Part Details | USP CLONAZEPAM TABLETS
6505-01-049-6735
Alternate Parts: NDC00228300311, NDC00228-3003-11, NDC00228300311, NDC00228-3003-11, NDC00378191001, NDC00378-1910-01, NDC00378191001, NDC00378-1910-01, NDC00093083201, NDC00093-0832-01, 6505-01-049-6735, 01-049-6735, 6505010496735, 010496735
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | OCT 23, 1977 | 01-049-6735 | 33952 ( CLONAZEPAM TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-049-6735
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00228-3003-11 | 6LMB8 | ACTAVIS PHARMA, INC. |
| NDC00228-3003-11 | 1SFA8 | ALPHARMA US PHARMACEUTICALS DIVISIONDBA ALPHARMA |
| NDC00378-1910-01 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC00378-1910-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC00093-0832-01 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-049-6735
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB0.500 MILLIGRAMS CLONAZEPAM |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| SPECIAL FEATURES | CLASS 4 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 0.5 MG 100S BT |